Navigation Links
Vermillion's OVA1 Receives New Statement by Society of Gynecologic Oncology
Date:6/11/2013

ed proof source for physicians and payers to assess OVA1's clinical performance and comparative medical benefits versus today's standard of care.
  • Places OVA1 use in the context of current ACOG practice guidelines, where CA125 has been used off-label for many years to predict malignancy before surgery, although with inferior performance.
  • Two key developments in 2013 underlined the timeliness of this updated statement by SGO. The first was the publication of the company's second pivotal clinical study, OVA500, in the February edition of Gynecologic Oncology. OVA500 was led by Dr. Robert E. Bristow, director of Gynecologic Oncology Services at UC Irvine Healthcare in Orange, California. The second development was a study in the June edition of the journal Obstetrics and Gynecology, which made the front page of the New York Times under the headline, "Widespread Flaws Found in Ovarian Cancer Treatment." This study, also led by Dr. Bristow, reported that most women with ovarian cancer "are treated by doctors and hospitals that see few cases of the disease and lack expertise in the complex surgery and chemotherapy that can prolong life." Dr. Bristow said, "If we could just make sure that women get to the people who are trained to take care of them, the impact would be much greater than that of any new chemotherapy drug or biological agent."

    After reviewing the SGO statement, Dr. Hector Chapa, MD, FACOG and medical director of the Women's Specialty Center in Dallas observed: "This new statement by SGO affirms the important role which OVA1 should play in the workup of patients with an adnexal mass, and particularly before surgery is undertaken by a surgeon uncertified in the gynecologic oncology specialty. This is important because a large number of malignancies are discovered after a surgery where the mass was thought to be benign after
    '/>"/>

    SOURCE Vermillion, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. The Renewable Corporation (RNWB) through its wholly owned subsidiary EcoSmart Surface & Coating Technologies receives results from Product Test Service.
    2. New York Blood Centers Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development
    3. CardioDx Receives College of American Pathologists (CAP) Accreditation
    4. Reproductive Medicine Associates of New Jersey Receives ACOG Prize for Paper on SET and CCS, a Pioneering IVF Process
    5. mPhase Technologies Receives Issue Notification Of Key Patent
    6. Heptares Achieves All Research Milestones and Receives Milestone Payment From GPCR Drug Discovery Agreement With Takeda
    7. Assurance Biosense, Inc. Receives FDA 510(k) Clearance
    8. DuPont Receives ‘Patents for Humanity’ Award for Groundbreaking Research to Improve Nutritional Profile of Staple Crop
    9. Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial
    10. Physicians for Peace Resource Mothers Program Receives Sweatshirt Blanket Donation
    11. Nerium International Receives the 2012 Global 100 Bravo Award for Growth
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
    (Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
    (Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. ... company focused on advanced wound care, announces that ... tissues, have been added to the Premier, Inc. ... the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product ...
    (Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
    Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
    ... on ... HeartMate II(R), PLEASANTON, Calif., Oct. 30 Thoratec,Corporation (Nasdaq: ... therapies to save, support and restore failing hearts,today said that ... revenues in the same period a year ago., Revenues ...
    ... (Nasdaq: ANDS ) announced today that it has ... virus (HCV) in Part B of a,two-part protocol designed ... ANA773 is the Company,s investigational oral TLR7 agonist,prodrug. In ... cohort will receive,800 mg of ANA773 every other day ...
    ... 30 In a joint press conference,Orange Romania ... cellular e-health service., "Health is the fundamental ... why,Orange and Medic4all are launching together the Medic4you ... Services Development,Manager for Orange Romania., Medic4you is ...
    Cached Biology Technology:Thoratec Reports 44 Percent Increase in Third Quarter Revenues 2Thoratec Reports 44 Percent Increase in Third Quarter Revenues 3Thoratec Reports 44 Percent Increase in Third Quarter Revenues 4Thoratec Reports 44 Percent Increase in Third Quarter Revenues 5Thoratec Reports 44 Percent Increase in Third Quarter Revenues 6Thoratec Reports 44 Percent Increase in Third Quarter Revenues 7Thoratec Reports 44 Percent Increase in Third Quarter Revenues 8Thoratec Reports 44 Percent Increase in Third Quarter Revenues 9Thoratec Reports 44 Percent Increase in Third Quarter Revenues 10Thoratec Reports 44 Percent Increase in Third Quarter Revenues 11Thoratec Reports 44 Percent Increase in Third Quarter Revenues 12Thoratec Reports 44 Percent Increase in Third Quarter Revenues 13Thoratec Reports 44 Percent Increase in Third Quarter Revenues 14Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients 2Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients 3Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients 4Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients 5Orange and Medic4all Launched the World's First Cellular Tele-Health Service 2
    (Date:12/22/2014)... 22, 2014 Research and Markets ( ... "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides ... and fingerprinting markets. Watermarking aims to control and ...
    (Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, today announced ... genetic ancestry of individuals from across the United ... than four hundred years ago, the United States ... from different continents. This study illuminates how American history and ...
    (Date:12/17/2014)... 2014  HITLAB SM announced today its completion of ... adherence to current U.S. Food and Drug Administration (FDA) ... device and smart phone application trials utilizing the highest ... "HITLAB is determined to improve global healthcare access, quality, ...
    Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
    ... vegetable juice a daily habit could be a small ... daily vegetable recommendations, according to a new study being ... week at the American Dietetic Association annual conference 1 ... short of the daily recommended vegetable intake as put ...
    ... 23 Paradigm Tactical,Products Inc. (Pink Sheets: PDGT.PK), ... solutions to the military as well as to,the ... agreement,which will make the company the largest distributor ... and four additional detector models in,the United States. ...
    ... when raised on low calorie diets. But now researchers at ... that they can extend the life spans of roundworms even ... a chemical that blocks their sense of smell. Three ... reported they found that a class of anticonvulsant medications made ...
    Cached Biology News:New study shows drinking your vegetables may be a solution to bridging the vegetable gap 2Paradigm Tactical Products to be Largest Distributor of Metal/Radiation Detection Wands in United States 2Paradigm Tactical Products to be Largest Distributor of Metal/Radiation Detection Wands in United States 3Deprived of a sense of smell, worms live longer 2
    ... biologic production demands on cell and tissue ... cell populations. Therefore, both cell concentration and ... accurately and precisely. The new Vi-CELLTM Cell ... effective means to perform the trypan blue ...
    ... is a post-translational modification that plays ... including immune regulation, inflammation, cell-to-cell adhesion, ... developed two lectin based Glycoprotein Isolation ... Germ Agglutinin (WGA), that allow isolation ...
    ... a powerful yet simple technology for labeling ... kit provides the heterobifunctional linkers SFB and ... efficiencies. It enables conjugation of various tags ... with a variety of proteins. , ...
    ... LS series of laser scanners is the ... Suite solution. ,Gene expression analysis, SNP ... essential to the advancement of research ... to novel microarray formats and sizes. These ...
    Biology Products: